" class="no-js "lang="en-US"> Anton Alexandroff - Medtech Alert
Friday, September 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Anton Alexandroff

Anton Alexandroff

About Anton Alexandroff

Dr Alexandroff FRCP PhD FAAD FRSM
is a consultant dermatologist fully trained in all areas of dermatology including acne, dermatitis, psoriasis, eczema, moles, skin cancers, phototherapy, cryotherapy, biologics, Botox, diphencyprone, dermoscopy and hair loss, alopecia. He has been treating patients with skin diseases for over 10 years. Dr Alexandroff contributed to dermatology textbooks and co-authored evidence based reports and reviews on diagnosis and treatment of various skin problems.

www.alexandroff.org.uk

twitter: @your_skin_dr

Related Story

Health Apps

 Miiskin Makes Use of Augmented Reality for New Mole Sizing Feature | Pharmtech Focus

Miiskin Makes Use of Augmented Reality for New Mole Sizing Feature

August 3 2021

Miiskin has launched a new mole sizing feature that uses augmented reality technology to enable […]